- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Ibrutinib – July 2015
Ibrutinib; 140 mg capsules, 90; Imbruvica®
Last updated
13 November 2015